JPS6154876B2 - - Google Patents
Info
- Publication number
- JPS6154876B2 JPS6154876B2 JP52112088A JP11208877A JPS6154876B2 JP S6154876 B2 JPS6154876 B2 JP S6154876B2 JP 52112088 A JP52112088 A JP 52112088A JP 11208877 A JP11208877 A JP 11208877A JP S6154876 B2 JPS6154876 B2 JP S6154876B2
- Authority
- JP
- Japan
- Prior art keywords
- formula
- group
- compound
- same
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
Description
本発明は環状アミン類の製造法に関する。
本発明方法により製造される化合物は一般式
(式中R1は水素原子又は炭素数1〜6のアルキル
基、Yは
The present invention relates to a method for producing cyclic amines. The compound produced by the method of the present invention has the general formula (In the formula, R 1 is a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, and Y is
【式】ただしR2及びR3
は水素原子、ヒドロキシ基、メトキシ基又はエト
キシ基であり、R4はR4が[Formula] However, R 2 and R 3 are hydrogen atoms, hydroxy groups, methoxy groups, or ethoxy groups, and R 4 is
【式】に結合してい
る場合には−CH2CH2−又は−CH=CH−であ
り、R4が−CH=と結合している場合にはNH、
O又はSである。あるいはYは
When bonded to [Formula], it is -CH 2 CH 2 - or -CH=CH-, and when R 4 is bonded to -CH=, it is NH,
O or S. Or Y is
【式】ただしR2及びR3は 上記と同じであり、R4は[Formula] However, R 2 and R 3 are the same as above, and R 4 is
【式】に結合し−
CH2CH2−又は−CH=CH−である。またR5は炭
素数1〜6のアルキル基又は
It is bonded to [Formula] and is -CH 2 CH 2 - or -CH=CH-. Moreover, R 5 is an alkyl group having 1 to 6 carbon atoms or
【式】ただしR9及びR7は水素原
子、ヒドロキシ基、メトキシ基又はエトキシ基で
ある。またXはC、Br又はI、あるいはR8SO3
基、ただしR8は弗素原子、メチル基、三弗化メ
チル基、フエニル基、p―トリル基又はナフチル
基である。)若しくは一般式
(式中Yは上記と同意義を有し、R10は炭素数3〜
8のアルキレン基であつて且つ第3番目、第4番
目又は第5番目の炭素上に置換基Xを有する、た
だしXはC、Br、I又はR11SO3である。ここ
でR11は弗素原子、メチル基、三弗化メチル基、
フエニル基、p―トリル基又はナフチル基であ
る。あるいはR10は[Formula] However, R 9 and R 7 are a hydrogen atom, a hydroxy group, a methoxy group, or an ethoxy group. and X is C, Br or I, or R 8 SO 3
group, provided that R 8 is a fluorine atom, a methyl group, a methyl trifluoride group, a phenyl group, a p-tolyl group, or a naphthyl group. ) or general formula (In the formula, Y has the same meaning as above, and R 10 has 3 to 3 carbon atoms.
8 alkylene group and has a substituent X on the third, fourth or fifth carbon, where X is C, Br, I or R 11 SO 3 . Here, R 11 is a fluorine atom, a methyl group, a methyl trifluoride group,
It is a phenyl group, p-tolyl group or naphthyl group. Or R10 is
【式】で表わ
され、R12、R13及びR14は水素原子、ヒドロキシ
基、メトキシ基又はエトキシ基であり、Xは上記
に同じ)で表わされる環状アミン類である。
本発明の上記環状アミン類1及び2は医薬とし
て有用であり、特に血圧降下剤、鎮痛剤、抗腫瘍
剤、殺菌剤等として有用である。また本発明の環
状アミン類は上記と同じ用途を有するイソキノリ
ンアルカロイド系医薬の中間体としても有用であ
る。
従来からの上記環状アミン類の製造法は複雑で
且つ長い工程を必要とするか、若しくは非常に高
価な薬品或いは危険な薬品を使用し、環境保全上
問題の多い方法であつた。
本発明方法によつて得られる目的化合物は出発
原料として容易に製造可能な下記一般式
(式中Y及びR1は前記に同じ、Zは陰イオンを示
す。)で表わされる化合物を一般式R5X(式中R5
及びXは前記に同じ)で表わされる求電子試薬の
存在下に電極還元することにより容易に得られ
る。
また本発明方法による目的化合物は一般式
(式中Y及びZは前記に同じ、R9はR10Xで表わさ
れ、R10は前記に同じ)で表わされる化合物を電
極還元することにより容易に得られる。
本発明の上記反応を更に詳しく説明すると一般
に反応式
(ただしR′、R″及びRは任意の置換基)で表わ
されるが如きインモニウム塩の還元的アルキル化
反応は、グリニヤル試薬或いはアルキルリチウム
の如き試薬を用いて、ある限られた範囲内でのみ
可能であるが、このような場合においてもその収
率は良好でなく、また反応も容易でない。更にこ
の方法の大きな欠点はグリニヤル試薬又はアルキ
ルリチウムの如き特殊な試薬は極めて限られた化
合物においてのみ調製可能であり、またその反応
条件も非常に特殊なものであつて、本発明方法が
目的としているが如き微妙な構造を有する環状ア
ミン類の製造に利用することは不可能である。
これに対して本発明の製造法は上記反応式にお
いて極めて広範囲なR′、R″及びRに対して適
用できる、他に比較する対象の全く無い独創的な
新規製造法であり、次の様な従来の製造法には見
られなかつた多くの長所を有する画期的な方法で
ある。
(イ) 原料の入手が容易であること
(ロ) 非常に簡単に且つ安全な操作で目的物が得ら
れること
(ハ) 選択性良く、好収率であると共に、工程が非
常に短いこと
(ニ) 分離しがたい異性体の副生がないこと
(ホ) 特殊な或いは環境保全上問題を有するような
化学薬品を全く使用しないこと
本発明の出発原料は下記反応式に示した如く、
両化合物を有利には溶媒中で反応させることによ
り極めて容易に得ることができる。
(ただしY、Z、R1及びR9は前記に同じ)
上記式中Zは任意の陰イオンを示すものである
が、特に好ましい具体例としては例えばC、
Br、I、アルキルスルホネート基、アリールス
ルホネート基等を挙げることができる。
本発明の反応は上記化合物3をR5Xで表わされ
る求電子試薬の存在下に電極還元するか或いは上
記化合物4を電極還元する必常に簡単な反応であ
る。上記反応は通常適当な溶媒中で直流電流を通
ずることにより行なうのが良い。
溶媒としては例えば水、メタノール、エタノー
ルなどのアルコール類、ジメチルホルムアミド、
ジメチルスルホキシド、ヘキサメチルホスホルア
ミド等の非プロトン性極性溶媒、アセトニトリル
の如きニトリル類が使用できる。本反応は常温に
おいて進行するのが一つの特徴であるが勿論常温
以下の低温においてもあるいは加熱下においても
反応可能であり、例えば−10℃〜100℃の広い範
囲で実施可能である。しかし0℃〜常温で行うの
が最も有利である。通常、電極還元を行うに当つ
て溶媒系に直流電流を通ずるために適当な電解質
すなわち支持電解質を加えることが必要である。
本発明方法の場合には出発原料の溶液が既に電導
性を有するために、特に電解質を加える必要は無
いが、しかし通常支持電解質として用いられるス
ルホン酸、過塩素酸、カルボン酸等のアルカリ金
属塩、または第4級アンモニウム塩を共存させる
ことにより更に有利に反応の進行する場合もあ
る。
電極材質としては通常用いられるすべての材質
を用いることが可能であるが、白金、水銀、鉛ま
たは炭素等が特に有効である。また隔膜を用いる
ことも任意であるが、隔膜を用いた場合には陰極
室において反応を行うことは当然のことである。
電流および端子間電圧の値は用いる装置によつ
て、また反応の規模によつて最適の値が変化する
ものであつて、本発明の方法を実施する場合に用
いる装置または反応の規模は全く任意である。従
つて電流値および端子間電圧値も適宜に決定でき
る。しかし陰極の電極電位を制御することが有利
な結果を与える場合は多い。この場合の陰極電位
としては出発原料であるインモニウム塩の還元電
位を測定して、その付近の電位とするのが適当で
ある。
本発明の方法では出発原料から複雑な異性体を
副生することなく目的物が得られるので反応後の
精製は非常に容易であつて、反応終了後、抽出な
どの操作で目的物1または2を極めて純度良く且
つ高収率で得ることができる。また必要な場合に
はカラムクロマトグラフ法によつて容易に目的物
を精製することができる。
以下に本発明の実施例を示す。
実施例 1
鉛陰極および白金陽極を用い、素焼円筒を隔膜
として、8.13g(0.03モル)のイソキノリンメチ
オダイドと10.16g(0.06モル)の臭化ベンジル
を300mlのジメチルホルムアミドに溶解した溶液
を陰極室に入れ、陽極液としてはジメチルホルム
アミドにp―トルエンスルホン酸テトラエチルア
ンモニウム塩を支持電解質として加えた溶液を用
い陰極電位を1.8volt vs SCEに調節しながら常
温で電極還元し、3F/moleの電気量を通じた
後、エーテルで3回抽出する。エーテル抽出液を
飽和食塩水で洗浄した後、エーテルを減圧留去す
ると、1―ベンジル―2―メチル―1,2ジヒド
ロイソキノリンが90%の収率で得られた。次いで
このものの一部を50mlの水および50mlのエタノー
ルの混合物に溶解し、苛性ソーダ1g、NaBH41
gを加えて5時間加熱還流し、還元したのち、エ
タノールおよび水を留去して、さらにエーテル抽
出する。次にエーテルを留去して残留物をカラム
クロマトグラフで精製して、1―ベンジル―2―
メチル―1,2,3,4―テトラヒドロイソキノ
リンを収率90%で得る。この生成物のNMRスペ
クトルはδ2.40(3H)、δ3.80(1H)、δ6.70〜
7.25(9H)に特有の吸収を示し、標準化合物と
全く一致した。
実施例 2
8.13g(0.03モル)のイソキノリンメチオダイ
ドと12.06g(0.06モル)の臭化p―メトキシベ
ンジルを用い、実施例1と同様に反応させ、1―
(p―メトキシベンジル)―2―メチル―1,2
―ジヒドロイソキノリンを収率95%で得た。この
化合物を実施例1と同様にしてNaBH4で還元し
て1―(p―メトキシベンジル)―2―メチル―
1,2,3,4―テトラヒドロイソキノリンを収
率95%で得る。この生成物のNMRはδ2.40
(3H)、δ3.68(3H)、δ6.25〜7.05(8H)に特有
の吸収を示し、標準化合物と完全に一致した。
実施例 3
8.13g(0.03モル)のイソキノリンメチオダイ
ドと13.86g(0.06モル)の臭化3,4―ジメト
キシベンジルを用い、実施例1と同様に電極還元
して1―(3,4―ジメトキシベンジル)―2―
メチル―1,2―ジヒドロイソキノリンを収率70
%で得た。この化合物を実施例1と同様に還元し
て1―(3,4―ジメトキシベンジル)―2―メ
チル―1,2,3,4―テトラヒドロイソキノリ
ンを収率93%で得る。この生成物のNMRはδ
2.40(3H)、δ3.58(3H)、δ3.70(3H)、δ2.20
(1H)、δ6.50〜6.95(7H)に特有の吸収を示
し、標準化合物と一致した。
実施例 4
1g(0.003モル)の化合物(A)
と2.13g(0.015モル)の沃化メチルとを、70ml
のジメチルホルムアミドに溶解した溶液を実施例
1と同様に電極還元して式
で表わされる目的物を収率65%で得た。b・
p170℃/1mmHgであつて分献値と一致した。
実施例 5
1g(0.003ル)の化合物(A)と1.2g(0.006モ
ル)の臭化p―メトキシベンジルとを70mlのジメ
チルホルムアミドに溶解した溶液を実施例1と同
様に電極還元して式
で表わされる目的物を収率90%で得た。このもの
はNMRδ2.35(3H)、δ3.46(3H)、δ5.90〜
6.95(6H)でこれは標準物質と一致した。
実施例 6
1g(0.003モル)の化合物(A)と1.4g(0.006モ
ル)の臭化3,4―ジメトキシベンジルとを70ml
のジメチルホルムアミドに溶解した溶液を実施例
1と同様に電極還元して、1―(3,4―ジメト
キシベンジル)―2―メチル―6,7―ジメトキ
シ―1,2,3,4テトラヒドロイソキノリン
(ローダノシン)を収率90%で得た。融点89℃。
実施例 7
0.765g(0.003モル)の化合物(B)
と1.4g(0.006モル)の臭化3,4―ジメトキベ
ンジルとを70mlのジメチルホルムアミドに溶解し
た溶液を水銀を陰極とし、その他の条件は実施例
1の方法と同様にして電極還元して、1―(3,
4―ジメトキシベンジル)―6,7―ジメトキシ
―1,2,3,4―テトラヒドロイソキノリン
(テトラヒドロパパベリン)を収率80%で得た。
元素分析値はC,69.90%;H,7.37%;N,
4.13%で理論値と良く一致した。
実施例 8
イソキノリンとo―キシリレンジブロミドとか
ら生成させたインモニウム塩(C)
の1.18g(0.003モル)をジメチルホルムアミド
70mlに溶解した溶液を実施例1と同様にして電極
還元して式
で表わされる化合物を収率80%で得た。この化合
物を実施例1と同様にして還元して式
で表わされるベルビンを得た。この化合物の融点
は83℃で標準品と一致した。
実施例 9
イソキノリンと1,3―トリメチレンジブロミ
ドとから得られるインモニウム塩(D)
の1g(0.003モル)をジメチルホルムアミド70
mlに溶解した溶液を実施例1と同様にして電極還
元して1,2―プロピレン―1,2―ジヒドロイ
ソキノリンを収率60%で得た。この化合物を実施
例1と同様にして還元して式
で表わされる1,2―プロピレン―1,2,3,
4―テトラヒドロイソキノリンを収率97%で得
た。この化合物の元素分析値はC,83.02%;
H,8.76%;N,8.22%で理論値と一致した。
実施例 10
1.37g(0.003モル)の化合物(E)
を70mlのジメチルホルムアミドに溶解した溶液を
実施例1と同様にして電極還元して式
で表わされる目的物を収率70%で得た。この化合
物のNMRスペクトルはδ3.60(3H),δ3.72
(3H),δ6.28(1H),δ6.40(1H),δ6.95−
7.05(4H)でその構造と一致した。
実施例 11
1.5g(0.003モル)の化合物(F)
を70mlのジメチルホルムアミドに溶解した溶液を
水銀を陰極として電極還元して式
で表わされる目的物を(ザイロパイニン)収率70
%で得た。この化合物の融点は1147―148℃で標
準品と完全に一致した。
実施例 12
1.38g(0.003モル)の化合物(G)
を70mlのジメチルホルムアミドに溶解し、水銀を
陰極として実施例1と同様にして電極還元して式
で表わされる目的物を収率80%で得た。この化合
物のNMRスペクトルはδ3.80(3H),δ3.75
(3H),δ5.9―7.0(6H)で構造式と一致した。
実施例 13
14.8g(0.003モル)の化合物(H)
を70mlのジメチルホルムアミドに溶解し、水銀を
陰極として実施例1と同様にして電極還元して式
で表わされる目的物を収率70%で得た。この化合
物の元素分析値はC,75.45%;H,6.68%;
N,8.35%であつて理論値と良く一致した。It is a cyclic amine represented by the formula: where R 12 , R 13 and R 14 are a hydrogen atom, a hydroxy group, a methoxy group or an ethoxy group, and X is the same as above. The cyclic amines 1 and 2 of the present invention are useful as medicines, particularly as antihypertensive agents, analgesics, antitumor agents, bactericidal agents, and the like. The cyclic amines of the present invention are also useful as intermediates for isoquinoline alkaloid drugs having the same uses as mentioned above. Conventional methods for producing the above-mentioned cyclic amines require complicated and long steps, or use very expensive or dangerous chemicals, resulting in many problems in terms of environmental protection. The target compound obtained by the method of the present invention has the following general formula which can be easily produced as a starting material. (In the formula, Y and R 1 are the same as above, and Z represents an anion.) A compound represented by the general formula R 5 X (in the formula, R 5
and X are the same as above) by electrode reduction in the presence of an electrophilic reagent. In addition, the target compound obtained by the method of the present invention has the general formula (In the formula, Y and Z are the same as above, R 9 is represented by R 10 X, and R 10 is the same as above) by electrode reduction. To explain the above reaction of the present invention in more detail, the general reaction formula is The reductive alkylation reaction of immonium salts such as those represented by R', R'' and R are arbitrary substituents can be carried out within a certain limited range using a reagent such as a Grignard reagent or an alkyl lithium. However, even in such cases, the yield is not good and the reaction is not easy.Furthermore, a major drawback of this method is that special reagents such as Grignard reagents or alkyl lithiums cannot be used for very limited compounds. Moreover, the reaction conditions are very special, and it cannot be used to produce cyclic amines with delicate structures such as those aimed at by the method of the present invention. On the other hand, the production method of the present invention is an original new production method that can be applied to an extremely wide range of R', R'' and R in the above reaction formula, and has no other targets for comparison. This is an innovative method that has many advantages not found in conventional manufacturing methods. (b) The raw materials are easily available (b) The target product can be obtained with very simple and safe operations (c) The process is very short with good selectivity and yield ( d) There is no by-product of isomers that are difficult to separate.(e) There is no use of any special or environmentally friendly chemicals.The starting materials of the present invention are as shown in the reaction formula below.
It can be obtained very easily by reacting both compounds, preferably in a solvent. (However, Y, Z, R 1 and R 9 are the same as above.) In the above formula, Z represents any anion, and particularly preferred examples include C,
Examples include Br, I, an alkylsulfonate group, and an arylsulfonate group. The reaction of the present invention is necessarily a simple reaction in which the above compound 3 is electrolytically reduced in the presence of an electrophilic reagent represented by R 5 X, or the above compound 4 is electrolytically reduced. The above reaction is usually carried out in a suitable solvent by passing a direct current through it. Examples of solvents include water, alcohols such as methanol and ethanol, dimethylformamide,
Aprotic polar solvents such as dimethyl sulfoxide and hexamethylphosphoramide, and nitriles such as acetonitrile can be used. One of the characteristics of this reaction is that it proceeds at room temperature, but of course it can also be carried out at a low temperature below room temperature or under heating, for example in a wide range of -10°C to 100°C. However, it is most advantageous to carry out the reaction at temperatures between 0°C and room temperature. Typically, it is necessary to add a suitable or supporting electrolyte to pass a direct current through the solvent system in carrying out electrode reduction.
In the case of the method of the present invention, since the starting material solution already has conductivity, there is no need to add an electrolyte. In some cases, the reaction may proceed more favorably by coexisting a quaternary ammonium salt or a quaternary ammonium salt. All commonly used materials can be used as the electrode material, but platinum, mercury, lead, carbon, etc. are particularly effective. It is also optional to use a diaphragm, but when a diaphragm is used, it is a matter of course that the reaction is carried out in the cathode chamber. The optimum values of the current and terminal voltage vary depending on the equipment used and the scale of the reaction, and the equipment or scale of the reaction used when carrying out the method of the present invention is completely arbitrary. It is. Therefore, the current value and the voltage value between the terminals can also be appropriately determined. However, controlling the electrode potential of the cathode often provides advantageous results. In this case, the cathode potential is suitably determined by measuring the reduction potential of the immonium salt as the starting material, and setting the potential to be around that range. In the method of the present invention, the target product can be obtained from the starting materials without producing complex isomers as by-products, so purification after the reaction is very easy. can be obtained with extremely high purity and high yield. Furthermore, if necessary, the target product can be easily purified by column chromatography. Examples of the present invention are shown below. Example 1 A lead cathode and a platinum anode were used, and a clay cylinder was used as a diaphragm. A solution of dimethylformamide and p-toluenesulfonic acid tetraethylammonium salt was added as a supporting electrolyte was used as the anolyte, and electrode reduction was performed at room temperature while adjusting the cathode potential to 1.8 volts vs. SCE. After evaporation, extract with ether three times. After washing the ether extract with saturated brine, the ether was distilled off under reduced pressure to obtain 1-benzyl-2-methyl-1,2 dihydroisoquinoline with a yield of 90%. A portion of this was then dissolved in a mixture of 50 ml of water and 50 ml of ethanol, 1 g of caustic soda, 1 g of NaBH 4 1
After reducing the mixture by heating and refluxing for 5 hours, ethanol and water were distilled off, and the mixture was further extracted with ether. Next, the ether was distilled off, the residue was purified by column chromatography, and 1-benzyl-2-
Methyl-1,2,3,4-tetrahydroisoquinoline is obtained with a yield of 90%. The NMR spectra of this product are δ2.40 (3H), δ3.80 (1H), δ6.70 ~
It showed a unique absorption at 7.25 (9H), which completely matched that of the standard compound. Example 2 8.13 g (0.03 mol) of isoquinoline methiodide and 12.06 g (0.06 mol) of p-methoxybenzyl bromide were reacted in the same manner as in Example 1, and 1-
(p-methoxybenzyl)-2-methyl-1,2
-Dihydroisoquinoline was obtained in a yield of 95%. This compound was reduced with NaBH 4 in the same manner as in Example 1 to obtain 1-(p-methoxybenzyl)-2-methyl-
1,2,3,4-tetrahydroisoquinoline is obtained with a yield of 95%. The NMR of this product is δ2.40
(3H), δ3.68 (3H), and δ6.25 to 7.05 (8H), which completely matched those of the standard compound. Example 3 1-(3,4- dimethoxybenzyl)-2-
Yield of methyl-1,2-dihydroisoquinoline 70
Obtained in %. This compound is reduced in the same manner as in Example 1 to obtain 1-(3,4-dimethoxybenzyl)-2-methyl-1,2,3,4-tetrahydroisoquinoline in a yield of 93%. The NMR of this product is δ
2.40 (3H), δ3.58 (3H), δ3.70 (3H), δ2.20
(1H) and δ6.50 to 6.95 (7H), which were consistent with the standard compound. Example 4 1 g (0.003 mol) of compound (A) and 2.13g (0.015mol) of methyl iodide in 70ml
A solution dissolved in dimethylformamide was reduced with the electrode in the same manner as in Example 1 to obtain the formula The target product represented by was obtained in a yield of 65%. b・
The p value was 170°C/1 mmHg, which agreed with the fractional value. Example 5 A solution of 1 g (0.003 mol) of compound (A) and 1.2 g (0.006 mol) of p-methoxybenzyl bromide dissolved in 70 ml of dimethylformamide was reduced with the electrode in the same manner as in Example 1 to obtain the formula The desired product represented by was obtained in a yield of 90%. This one has NMR δ2.35 (3H), δ3.46 (3H), δ5.90 ~
6.95 (6H), which was consistent with the standard. Example 6 1 g (0.003 mol) of compound (A) and 1.4 g (0.006 mol) of 3,4-dimethoxybenzyl bromide in 70 ml
A solution of 1-(3,4-dimethoxybenzyl)-2-methyl-6,7-dimethoxy-1,2,3,4tetrahydroisoquinoline ( Rhodanosine) was obtained in 90% yield. Melting point: 89℃. Example 7 0.765g (0.003mol) of compound (B) A solution prepared by dissolving 1.4 g (0.006 mol) of 3,4-dimethoxybenzyl bromide in 70 ml of dimethylformamide was subjected to electrode reduction using mercury as the cathode and using the other conditions as in Example 1. ,1-(3,
4-dimethoxybenzyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline (tetrahydropapaverine) was obtained in a yield of 80%. Elemental analysis values are C, 69.90%; H, 7.37%; N,
It was 4.13%, which was in good agreement with the theoretical value. Example 8 Immonium salt (C) produced from isoquinoline and o-xylylene dibromide 1.18g (0.003mol) of dimethylformamide
The solution dissolved in 70 ml was reduced with the electrode in the same manner as in Example 1, and the formula The compound represented by was obtained in a yield of 80%. This compound was reduced in the same manner as in Example 1 to give the formula We obtained Belbin expressed as . The melting point of this compound was 83°C, which was consistent with the standard. Example 9 Immonium salt (D) obtained from isoquinoline and 1,3-trimethylene dibromide 1g (0.003 mol) of dimethylformamide 70
ml of the solution was subjected to electrode reduction in the same manner as in Example 1 to obtain 1,2-propylene-1,2-dihydroisoquinoline in a yield of 60%. This compound was reduced in the same manner as in Example 1 to give the formula 1,2-propylene-1,2,3, represented by
4-Tetrahydroisoquinoline was obtained with a yield of 97%. The elemental analysis value of this compound is C, 83.02%;
H, 8.76%; N, 8.22%, which agreed with the theoretical values. Example 10 1.37g (0.003mol) of compound (E) was dissolved in 70 ml of dimethylformamide and reduced by electrode in the same manner as in Example 1 to obtain The target product represented by was obtained in a yield of 70%. The NMR spectrum of this compound is δ3.60 (3H), δ3.72
(3H), δ6.28 (1H), δ6.40 (1H), δ6.95−
7.05 (4H), which matched the structure. Example 11 1.5 g (0.003 mol) of compound (F) Dissolved in 70 ml of dimethylformamide, reduce the solution with an electrode using mercury as a cathode to obtain the formula Yield of the target product (zylopinin) expressed as 70
Obtained in %. The melting point of this compound was 1147-148℃, which completely matched that of the standard product. Example 12 1.38g (0.003mol) of compound (G) was dissolved in 70 ml of dimethylformamide and reduced with the electrode in the same manner as in Example 1 using mercury as the cathode to obtain the formula The target product represented by was obtained in a yield of 80%. The NMR spectrum of this compound is δ3.80 (3H), δ3.75
(3H) and δ5.9−7.0 (6H), which matched the structural formula. Example 13 14.8 g (0.003 mol) of compound (H) was dissolved in 70 ml of dimethylformamide and reduced with the electrode in the same manner as in Example 1 using mercury as the cathode to obtain the formula The target product represented by was obtained in a yield of 70%. The elemental analysis values of this compound are C, 75.45%; H, 6.68%;
N, 8.35%, which was in good agreement with the theoretical value.
Claims (1)
基、Yは【式】ただしR2及びR3 は水素原子、ヒドロキシ基、メトキシ基又はエト
キシ基であり、R4はR4が【式】に結合してい る場合には−CH2CH2−又は−CH=CH−であ
り、R4が−CH=と結合している場合にはNH、
O又はSである。あるいはYは
【式】ただしR2及びR3は 上記と同じであり、R4は【式】に結合し− CH2CH2−又は−CH=CH−である。またZは陰
イオンを示す。)で表わされる化合物を一般式 R5X (式中R5は炭素数1〜6のアルキル基又は
【式】ただしR6及びR7は水素原 子、ヒドロキシ基、メトキシ基又はエトキシ基で
ある。またXはC、Br又はI、あるいはR8SO3
基、ただしR8は弗素原子、メチル基、三弗化メ
チル基、フエニル基、p―トリル基又はナフチル
基である。)で表わされる求電子試薬の存在下に
電極還元することを特徴とする一般式 (式中R1、Y及びR5は上記と同じ)で表わされる
環状アミン類の製造法。 2 一般式 (式中Yは特許請求の範囲第1項に記載のYと同
意義を有し、R9はR10Xで表わされ、R10は炭素数
3〜8のアルキレン基であつて且つ第3番目、第
4番目又は第5番目の炭素上に置換基Xを有す
る、ただしXはC、Br、I又はR11SO3であ
る。ここでR11は弗素原子、メチル基、三弗化メ
チル基、フエニル基、p―トリル基又はナフチル
基である。あるいはR10Xは
【式】で表わされ、R12、R13及び R14は水素原子、ヒドロキシ基、メトキシ基又は
エトキシ基であり、Xは上記に同じ、またZは陰
イオンを示す。)で表わされる化合物を電極還元
することを特徴とする一般式 (式中Y及びR10は上記に同じ)で表わされる環状
アミン類の製造法。[Claims] 1. General formula (In the formula, R 1 is a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, Y is When bonded to [Formula], it is -CH 2 CH 2 - or -CH=CH-, and when R 4 is bonded to -CH=, it is NH,
O or S. Alternatively, Y is [Formula], where R 2 and R 3 are the same as above, and R 4 is bonded to [Formula] and is -CH 2 CH 2 - or -CH=CH-. Moreover, Z represents an anion. ) is a compound represented by the general formula R 5 and X is C, Br or I, or R 8 SO 3
group, provided that R 8 is a fluorine atom, a methyl group, a methyl trifluoride group, a phenyl group, a p-tolyl group, or a naphthyl group. ) A general formula characterized by electrode reduction in the presence of an electrophilic reagent A method for producing cyclic amines represented by the formula (wherein R 1 , Y and R 5 are the same as above). 2 General formula (In the formula, Y has the same meaning as Y described in claim 1, R9 is represented by R10X , R10 is an alkylene group having 3 to 8 carbon atoms, and Has a substituent X on the third, fourth or fifth carbon, where X is C, Br, I or R 11 SO 3 , where R 11 is a fluorine atom, a methyl group, a trifluoride A methyl group , a phenyl group, a p-tolyl group , or a naphthyl group. Alternatively, R 10 , X is the same as above, and Z represents an anion.) A general formula characterized by electrode reduction of a compound represented by A method for producing cyclic amines represented by the formula (wherein Y and R 10 are the same as above).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11208877A JPS5446787A (en) | 1977-09-16 | 1977-09-16 | Manufacture of cyclic amines |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11208877A JPS5446787A (en) | 1977-09-16 | 1977-09-16 | Manufacture of cyclic amines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5446787A JPS5446787A (en) | 1979-04-12 |
| JPS6154876B2 true JPS6154876B2 (en) | 1986-11-25 |
Family
ID=14577788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11208877A Granted JPS5446787A (en) | 1977-09-16 | 1977-09-16 | Manufacture of cyclic amines |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5446787A (en) |
-
1977
- 1977-09-16 JP JP11208877A patent/JPS5446787A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5446787A (en) | 1979-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8357807B2 (en) | Isoquinolinium compounds useful in the preparation of cisatracurium and associated intermediates | |
| US8293912B2 (en) | Process for producing cisatracurium compounds and associated intermediates | |
| NZ739993A (en) | Method for the preparation of (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carboxamide and recovery of (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carboxamide by electrochemical methods | |
| US9481679B2 (en) | Process for the preparation of tofacitinib and intermediates thereof | |
| Van der Plas et al. | The. sigma. adducts of 5-nitropyrimidines with liquid ammonia and their oxidation into aminonitropyrimidines | |
| CN101517128B (en) | Electrochemical production of sterically hindered amines | |
| JPS6154876B2 (en) | ||
| US20160017505A1 (en) | Electrochemical coupling of a phenol to a naphthol | |
| US4408063A (en) | Preparation of epihalohydrin enantiomers | |
| US4350636A (en) | Preparation of phenylacetonitriles carrying basic substituents | |
| Barton et al. | Phenol oxidation and biosynthesis. Part XXV. New syntheses of bis-(2-arylethyl) amines of biosynthetic importance | |
| US10131607B2 (en) | Process for preparing unsymmetric OCO pincer ligands from the group of the M-terphenyl compounds | |
| KR101862824B1 (en) | Process for the enantioselective synthesis of landiolol | |
| DE102015215997A1 (en) | Phenol-arene coupling product | |
| US3179691A (en) | Method of producing dichloro-benzonitriles | |
| CN114395771B (en) | A method for deoxygenation reduction of aldehydes and ketones to corresponding saturated hydrocarbons | |
| CN115215803B (en) | Preparation method of 4-halogenated-1- (difluoromethyl) -1H-imidazole | |
| JPS622037B2 (en) | ||
| JPH0136818B2 (en) | ||
| CN113930791B (en) | Electric synthesis method of pyrido-bipyrimidine tetraketone compound | |
| JPH0144711B2 (en) | ||
| RU2575174C1 (en) | METHOD OF OBTAINING DERIVATIVES OF 5,6-DIHYDROPYRROLO[2,1-a]ISOQUINOLINES, WHICH CONTAIN FUNCTIONAL GROUP IN POSITION 2 | |
| CA1074305A (en) | Amino-substituted tetracyclic compounds | |
| WO2006062477A1 (en) | Chemical process | |
| JPH027583B2 (en) |